• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

ASM Opening Northwest

































He’s a fake at the manager meeting he try’s to act he cares but it all boils down to numbers with him. Talked to us about putting bottom 15-20% of our teams on PIP’s but we fought him on that
This wasn’t brought up at the manager meetings but when he has calls with us his reflex being from big Pharma is PIP’s or action plans to change behaviors so that numbers might get better.